/PRNewswire/ Grey Wolf Therapeutics ("Grey Wolf" or "the company"), a clinical-stage biotechnology company leveraging first-of-its-kind antigen modulation.
MinterEllisonRuddWatts advised amicaa, an Australian private credit manager, and The Carlyle Group on all aspects of their debt financing. The loan includes sustainability-linked incentives to support NPD in meeting Scope 3 emission targets.
Community Scoop » MinterEllisonRuddWatts Advises Amicaa And The Carlyle Group On NZ$140 Mn Financing Package For Management Buyout Of NPD scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.
Sydney, Australia, May 22, 2024 - Global investment firm Carlyle and amicaa, an Australian private credit manager, today announced they will provide a NZ$140 million debt financing.